Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder

S Pliszka… - Journal of the American …, 2007 - Elsevier
This practice parameter describes the assessment and treatment of children and
adolescents with attention-deficit/hyperactivity disorder (ADHD) based on the current …

A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)

A Sharma, J Couture - Annals of Pharmacotherapy, 2014 - journals.sagepub.com
Objective: To review the pathophysiology, etiology, and treatment of attention-deficit
hyperactivity disorder (ADHD). Data Sources and Data Extraction: A literature search was …

Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents

ML Wolraich, JF Hagan, C Allan, E Chan… - …, 2019 - publications.aap.org
OBJECTIVES: We examined overall and incremental effectiveness of 2-dose varicella
vaccination in preventing community transmission of varicella among children aged 4 to 18 …

Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies

JPC Chang, KP Su, V Mondelli… - …, 2018 - nature.com
The role of omega-3 polyunsaturated fatty acids (omega-3 or n-3 PUFAs) in the
pathogenesis and treatment of children and adolescents with attention deficit hyperactivity …

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

S Cortese, M Holtmann, T Banaschewski… - Journal of Child …, 2013 - Wiley Online Library
Background: Medication is an important element of therapeutic strategies for ADHD. While
medications for ADHD are generally well‐tolerated, there are common, although less …

Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis

S Carucci, C Balia, A Gagliano, A Lampis… - Neuroscience & …, 2021 - Elsevier
Background Methylphenidate (MPH) is an efficacious treatment for ADHD but concerns have
been raised about potential adverse effects of extended treatment on growth. Objectives To …

Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature

S Cortese, M Angriman, C Maffeis, P Isnard… - Critical reviews in …, 2008 - Taylor & Francis
Recent studies suggest a possible comorbidity between Attention-Deficit/Hyperactivity
Disorder (ADHD) and obesity. To gain insight into this potential association, we performed a …

Impulsive aggression as a comorbidity of attention-deficit/hyperactivity disorder in children and adolescents

KE Saylor, BH Amann - Journal of child and adolescent …, 2016 - liebertpub.com
Objective: This article examines the characteristics of impulsive aggression (IA) as a
comorbidity in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) …

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents

KP Garnock-Jones, GM Keating - Pediatric Drugs, 2009 - Springer
Atomoxetine (Strattera®) is a selective norepinephrine (noradrenaline) reuptake inhibitor
that is not classified as a stimulant, and is indicated for use in patients with attention-deficit …

A family–school intervention for children with ADHD: Results of a randomized clinical trial.

TJ Power, JA Mautone, SL Soffer… - Journal of consulting …, 2012 - psycnet.apa.org
Objective: Accumulating evidence highlights the importance of using psychosocial
approaches to intervention for children with attention-deficit/hyperactivity disorder (ADHD) …